Sanquin Blood Supply Foundation’s Sale of a Majority Stake of Sanquin Plasma Products BV

Waselius & Wist represented Sanquin Blood Supply Foundation on the deal.

Sanquin Blood Supply Foundation announced the sale of a majority stake of Sanquin Plasma Products BV to a consortium of investors in the biomedical sector.

Sanquin Plasma Products BV produces a wide range of plasma-based pharmaceuticals for global distribution.

Sanquin Blood Supply Foundation is responsible for the blood supply in the Netherlands, and is affiliated to the University of Amsterdam and other universities in the Netherlands.

Sanquin Research performs basic, applied, and clinically oriented research in the field of blood and blood transfusion. Our research is focussed on haematology, blood coagulation, immunology, cellular therapies and donor studies. Sanquin offers an international, competitive, multidisciplinary research environment with state-of-the-art facilities.

The Waselius & Wist team included Christoffer Waselius (Picture), Lotta Pohjanpalo and Kim Ekqvist.

Involved fees earner: Kim Ekqvist – Waselius & Wist; Lotta Pohjanpalo – Waselius & Wist; Christoffer Waselius – Waselius & Wist;

Law Firms: Waselius & Wist;

Clients: Sanquin Blood Supply Foundation;